Form D · Pharmaceuticals
Amarantus Bioscience Holdings, Inc.
San Francisco, CA · CIK 0001424812
Offering snapshot reported Mar 12, 2018 · SEC filing
- Reported sold
- $300K Offering amount: $1.5M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 12, 2018 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Nov 17, 2014 | Initial | $3,000,000 | No comparison | 1 | SEC filing |
| Sep 13, 2013 | Initial | $1,390,000 | No comparison | 5 | SEC filing |
| Aug 28, 2013 | Initial | $1,299,327 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $37.5K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-307539
Dominick & Dickerman LLC will receive fees in the amount of 1.25% of the amount of securities sold and Paulson Investment Company LLC will receive fees in the amount of 11.25% of the amount of securities sold.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Dominick & Dickerman LLC | 7344 | Steven Spence · CRD 2667444 |
| Paulson Investment Company LLC | 5670 | Zvi Ben-Zvi · CRD 2994766 |
Source: Form D, filed Mar 12, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Benedyk | Director |
| Gerald Commissiong | Director, Executive |
| Dr. John W Commissiong | Director, Executive |
| John Commissiong | Director, Executive |
| Marc Faerber | Executive |
| Robert Farrell | Executive |
| Robert Harris | Director |
| Donald Huffman | Director |
| David Lowe | Director |
| Iain Ross | Director |
| Steven Spence | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
953 Indiana Street
San Francisco, CA, 94104
San Francisco, CA, 94104